Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-31 @ 12:52 PM
Study NCT ID:
NCT04385303
Status:
COMPLETED
Last Update Posted:
2022-03-03
First Post:
2020-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis
Sponsor:
Biosplice Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-08
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-08
First Submit QC Date:
None
Study First Post Date:
2020-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-02-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-01
Last Update Post Date:
2022-03-03
Last Update Post Date Type:
ACTUAL